BIO Cash Flow Statement

Bio-Rad Laboratories Inc - Operating, Investing & Free Cash Flow Analysis

Operating Cash Flow

$532.20M

+16.9% YoY

Free Cash Flow

$374.60M

+40.7% YoY

FCF per Share

-

4.98% yield

CapEx

$157.60M

Operating Activities

Cash generated from core business operations

Net Cash from Operations

Primary cash generation

$532.20M
Net Income (Starting Point)$759.90M
+ Depreciation & Amortization$205.40M

Investing Activities

Cash used for investments and capital expenditures

Net Cash from Investing

Total investing activities

($189.70M)
Capital Expenditures (CapEx)$157.60M

Financing Activities

Cash from financing activities including debt, equity, and dividends

Net Cash from Financing

Total financing activities

($283.20M)

Free Cash Flow (FCF) Calculation

Operating Cash Flow$532.20M
- Capital Expenditures$157.60M
= Free Cash Flow$374.60M

Cash Flow Trends (Annual)

PeriodOperating CFInvesting CFFinancing CFFree CF
2025-12-31$532.20M($189.70M)($283.20M)$374.60M
2024-12-31$455.20M($160.20M)($218.80M)$266.20M
2023-12-31$374.94M$20.21M($425.65M)$218.26M
2022-12-31$194.45M($1.21B)$973.58M$80.29M
2021-12-31$656.52M($784.44M)($55.43M)$535.72M

View Complete Financial Analysis

Full income statements, balance sheets, and detailed cash flow analysis

Open Full Analysis

Frequently Asked Questions

What is BIO free cash flow?

BIO's most recent free cash flow (FCF) is $374.60M. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is available for dividends, buybacks, or debt reduction.

What is BIO operating cash flow?

BIO generated $532.20M in operating cash flow in the most recent period. Operating cash flow shows the cash generated from core business operations.

What is BIO FCF per share?

FCF per share can be calculated by dividing free cash flow by shares outstanding.

Is BIO cash flow growing?

BIO's operating cash flow grew by 16.9% year-over-year. Free cash flow increased by 40.7%.

What is BIO FCF yield?

BIO has a free cash flow yield of 4.98%, calculated as free cash flow divided by market capitalization. A higher FCF yield may indicate better value.

What is BIO capital expenditure?

BIO spent $157.60M on capital expenditures (CapEx) in the most recent period. CapEx represents investments in property, plant, and equipment.

Explore Categories